Making a difference in clinical trials: The impact of engagement
We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all.
Search
Research Institute of Molecular Pathology IMP
Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the Research Institute of Molecular Pathology (IMP) is a leading institute for biomedical researchin Vienna, Austria.
Data Privacy Notice for Customers, Partners, Visitors, Distributors and interested Persons
Data Privacy Notice for Customers, Partners, Visitors, Distributors and interested Persons
Data Privacy-Pharmacovigilance in Animal Health
Data Privacy Notice for Pharmacovigilance in Animal Health
Data Privacy-Pharmacovigilance Humanpharma
Cancer cell directed therapies
At Boehringer Ingelheim, we are investigating cancer cell directed therapies that target key cancer drivers and hallmarks to directly kill cancer cells.
Cat vaccination ten things you should know
Find out how you can keep your feline companion happy and healthy. 10 important questions about cat vaccination to help you make informed decisions about maintaining your cat’s health.
Always Here – Our Commitment for Ukraine
Boehringer Ingelheim has actively supported Ukrainian civilians throughout the Russian invasion.
AI as an assistant in research and development
Boehringer Ingelheim is helping to shape AI development as a pioneer.